Src homology phosphotyrosyl phosphatase‐2 expression is an independent negative prognostic factor in human breast cancer
- 26 March 2013
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 63 (1), 74-82
- https://doi.org/10.1111/his.12140
Abstract
Aims Src homology phosphotyrosyl phosphatase‐2 (SHP2) is a ubiquitously expressed phosphatase that plays an essential role in the downstream signalling pathways of multiple growth factor receptors, thus representing a potential target for cancer therapy. Recent studies suggest that SHP2 contributes to tumour initiation, progression and metastasis in breast cancer, yet the impact of SHP2 expression on prognosis in human breast cancer has not been evaluated. Methods and results To explore further the role of SHP2 in breast cancer, we conducted an immunohistochemical study using a tissue microarray encompassing 1401 formalin‐fixed breast cancer specimens with detailed clinical annotation and outcome data. Of 1401 evaluable breast cancers, 651 (46%) were positive for SHP2. SHP2 expression was associated positively with tumour grade, lymph node status and tumour stage. In univariate survival analysis, cases with SHP2 expression had a significantly worse overall survival (OS). In multivariate analysis, SHP2 remained an independent negative prognostic factor for OS. SHP2 expression was a negative prognostic factor for OS in the luminal A and the luminal B HER2− intrinsic subtypes. Conclusions Our data demonstrate for the first time that SHP2 is an independent predictor of survival in breast cancer, suggesting that SHP2 may be a potential target for therapy.Keywords
This publication has 26 references indexed in Scilit:
- Focal amplification and oncogene dependency of GAB2 in breast cancerOncogene, 2009
- Molecular Mechanism for SHP2 in Promoting HER2-induced Signaling and TransformationPublished by Elsevier BV ,2009
- SHP2 is up‐regulated in breast cancer cells and in infiltrating ductal carcinoma of the breast, implying its involvement in breast oncogenesisHistopathology, 2008
- Inhibition of SHP2 leads to mesenchymal to epithelial transition in breast cancer cellsCell Death & Differentiation, 2008
- The tyrosine phosphatase Shp2 (PTPN11) in cancerCancer and Metastasis Reviews, 2008
- Protein-tyrosine phosphatases and cancerNature Reviews Cancer, 2006
- How Signaling Promotes Stem Cell Survival: Trophoblast Stem Cells and Shp2Developmental Cell, 2006
- A role for the scaffolding adapter GAB2 in breast cancerNature Medicine, 2005
- Activating Mutations of the Noonan Syndrome-Associated SHP2/PTPN11 Gene in Human Solid Tumors and Adult Acute Myelogenous LeukemiaCancer Research, 2004
- Protein-tyrosine Phosphatase Shp-2 Regulates Cell Spreading, Migration, and Focal AdhesionPublished by Elsevier BV ,1998